Skip to main content
Caplight Logo









Freespira

Freespira

Private
Kirkland, WashingtonHealthcare & Life Scienceshttps://freespira.com/

Last Round

VC Round

Dec 8, 2020

Total Funding Raised

$12.48M

Company Overview

Freespira is a digital therapeutics company that provides an FDA-cleared, medication-free at-home treatment program for panic disorder and post-traumatic stress disorder.

Sector

Healthcare & Life Sciences

Verticals

Mental Health, Medical Devices, Patient Engagement

Business Model

B2B2C

Customer Profile

Hardware + Subscription, Revenue Share

AI Layer

Non-AI

Keywords

digital therapeuticDTxbiofeedbackcapnometrypanic disorder treatmentPTSD treatmentbreathing trainingat-home therapymental health techbehavioral healthoutcomes-based pricingvalue-based careremote monitoringnon-pharmaceutical treatmentmedtech

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Freespira Comparables

Compare Freespira with similar companies based on industry and business-model similarity.

Freespira comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Big Health
77%
PursueCare
73%
Click Therapeutics
70%

Freespira Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
VC RoundDec 8, 2020
Series BMar 3, 2016
Series AMar 9, 2015
Series AOct 2, 2013

Key People

Founding team and executive leadership

Debra Reisenthel

Founding CEO, Director

Founding Team

Joseph Perekupka

Chief Executive Officer

Executive Team

Freespira Investors

Notable investors and investment history

Freespira investors
InvestorRounds
Aphelion CapitalVC Round, Series A
Medvest CapitalVC Round, Series A
Lightspeed Venture PartnersVC Round

Market signals

Structured signals derived from secondary market and firmographic data.

  • Aug 21, 2026

    Monthly visitors increased 40% MoM.

  • Feb 1, 2026

    Launched fifth-generation device for at-home treatment of anxiety disorders.

Freespira Filings

Explore SEC and related filing metadata, where available.

Freespira filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Freespira's valuation, stock price, and market status.

Is Freespira a public or private company?

Freespira is a private company.

What is the current stock price of Freespira?

Freespira is a private company with no public stock price. No recent secondary market data is available.

How much is Freespira worth (valuation)?

Valuation information for Freespira is not publicly available.

Can I buy Freespira stock?

Freespira shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Freespira's last funding round?

Freespira's most recent funding round was VC Round on December 8, 2020.

Who are the main investors in Freespira?

Key investors in Freespira include Lightspeed Venture Partners.

Will Freespira IPO soon?

No public IPO plans have been announced for Freespira.

How can I track Freespira secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Freespira's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersKirkland, Washington
Employee Range29
Year Founded2013
Last FundingDec 8, 2020

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?